Sun Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SUN PHARM, and what generic alternatives to SUN PHARM drugs are available?
SUN PHARM has five hundred and fifty-two approved drugs.
There are forty-six US patents protecting SUN PHARM drugs. There are eighteen tentative approvals on SUN PHARM drugs.
There are three hundred and ninety-five patent family members on SUN PHARM drugs in fifty-seven countries and six hundred and nineteen supplementary protection certificates in nineteen countries.
Summary for Sun Pharm
| International Patents: | 395 |
| US Patents: | 46 |
| Tradenames: | 358 |
| Ingredients: | 331 |
| NDAs: | 552 |
| Patent Litigation for Sun Pharm: | See patent lawsuits for Sun Pharm |
| PTAB Cases with Sun Pharm as petitioner: | See PTAB cases with Sun Pharm as petitioner |
Drugs and US Patents for Sun Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma Global | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 078805-001 | Apr 21, 2008 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Sun Pharm Inds Ltd | ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE | ondansetron hydrochloride | INJECTABLE;INJECTION | 077173-001 | Dec 26, 2006 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Sun Pharm Inds Inc | HYDROCODONE BITARTRATE AND IBUPROFEN | hydrocodone bitartrate; ibuprofen | TABLET;ORAL | 091633-004 | May 28, 2013 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Sun Pharm Inds Inc | GEMFIBROZIL | gemfibrozil | TABLET;ORAL | 079239-001 | Dec 29, 2008 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Sun Pharm | CARBIDOPA AND LEVODOPA | carbidopa; levodopa | TABLET, ORALLY DISINTEGRATING;ORAL | 078690-002 | Jul 31, 2009 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-001 | May 25, 2012 | AB2 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Sun Pharma Global | ZOLEDRONIC ACID | zoledronic acid | INJECTABLE;INTRAVENOUS | 202746-001 | Mar 4, 2013 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Sun Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-003 | May 25, 2012 | 9,078,925 | ⤷ Subscribe |
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-003 | May 25, 2012 | 8,367,102 | ⤷ Subscribe |
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-002 | May 25, 2012 | 8,367,102 | ⤷ Subscribe |
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-006 | Aug 15, 2014 | 7,435,427 | ⤷ Subscribe |
| Sun Pharm Inds Inc | ULTRAVATE | halobetasol propionate | OINTMENT;TOPICAL | 019968-001 | Dec 17, 1990 | 4,619,921 | ⤷ Subscribe |
| Sun Pharm Inds Inc | LEVULAN | aminolevulinic acid hydrochloride | SOLUTION;TOPICAL | 020965-001 | Dec 3, 1999 | 5,079,262 | ⤷ Subscribe |
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-005 | Aug 15, 2014 | 9,089,534 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SUN PHARM drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-01-07 |
| ➤ Subscribe | Capsules | 25 mg | ➤ Subscribe | 2016-05-16 |
| ➤ Subscribe | Capsules | 35 mg | ➤ Subscribe | 2015-11-25 |
| ➤ Subscribe | Tablets | 125 mg | ➤ Subscribe | 2018-07-23 |
| ➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-06-19 |
| ➤ Subscribe | Capsules | 30 mg and 40 mg | ➤ Subscribe | 2012-12-31 |
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
International Patents for Sun Pharm Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2007247860 | ⤷ Subscribe |
| Denmark | 1421099 | ⤷ Subscribe |
| Lithuania | PA2015051 | ⤷ Subscribe |
| Poland | 2503004 | ⤷ Subscribe |
| World Intellectual Property Organization (WIPO) | 03014141 | ⤷ Subscribe |
| New Zealand | 600767 | ⤷ Subscribe |
| China | 102746285 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sun Pharm Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2465580 | SPC/GB21/030 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: CABOTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, INCLUDING CABOTEGRAVIR SODIUM.; REGISTERED: UK EU/1/20/1481 (NI) 20201221; UK PLGB 35728/0055-57 20201221 |
| 1667986 | 92172 | Luxembourg | ⤷ Subscribe | PRODUCT NAME: SOLVAT ACETONIQUE DU CABAZITAXEL, OU DESIGNE SOLVAT ACETONIQUE DU DIMETHOXY DOCETAXEL OU SOLVAT ACETONIQUE DU (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4-ACETOXY-2A-BENZOYLOXY-5BETA,20-EPOXY-1-HYDROXY-7BETA,10A-DIMETHOXY-9-OXO-TAX-11-ENE-13A-YLE(ACETONATE DU CABAZITAXEL) |
| 1746976 | LUC00026 | Luxembourg | ⤷ Subscribe | PRODUCT NAME: IRINOTECAN SUCROSOFATE SALT, SUCH AS IRINOTECAN SUCROSOFATE SALT IN A PEGYLATED LIPOSOME, SUCH AS A LIPOSOME COMPRISING 1,2-DISTEAROYL-SN-PHOSPHATIDYLCHOLINE, CHOLESTEROL AND N-(OMEGA-METHOXY-POLY(ETHYLENE GLYCOL) (MOLECULAR WEIGHT 2000)-OXYCARBONYL)-1,2-DISTEAROYLPHOSPHATIDYL ETHANOLAMINE, E.G. IN THE MOLAR RATIO 3:2:0.015; AUTHORISATION NUMBER AND DATE: EU/1/16/1130 20161018 |
| 0473687 | 3/1999 | Austria | ⤷ Subscribe | PRODUCT NAME: FOSPHENYTOIN-NATRIUM; NAT. REGISTRATION NO/DATE: 1-22664 19980728; FIRST REGISTRATION: GB 00019/0157 19980204 |
| 0473687 | SPC/GB98/030 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: FOSPHENYTOIN SODIUM (3-HYDROXYMETHYL)-5,5-DIPHENYLHYDANTOIN DISODIUM PHOSPHATE ESTER); REGISTERED: UK 0019/0157 19980204 |
| 2673237 | LUC00111 | Luxembourg | ⤷ Subscribe | PRODUCT NAME: SODIUM ZIRCONIUM CYCLOSILICATE; AUTHORISATION NUMBER AND DATE: EU/1/17/1173 20180326 |
| 1412357 | 50/2008 | Austria | ⤷ Subscribe | PRODUCT NAME: SITAGLIPTIN, GEGEBENENFALLS IN DER FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, INSBESONDERE ALS MONOPHOSPHAT, UND METFORMIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, INSBESONDERE DES HYDROCHLORIDS; NAT. REGISTRATION NO/DATE: EU/1/08/455/001-014, EU/1/08/456/001-014, EU/1/08/457/001-014 20080716; FIRST REGISTRATION: CH 58450 01-03 20080408 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
